Meyka Pro banner
Danaher Corporation

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHR●NYSE
HealthcareMedical - Diagnostics & Research
$226.11
$1.22(0.54%)
U.S. Market opens in 14h 6m

Danaher Corporation (DHR)

Meyka AI Score

Z

Key Financials

Market Cap159B
P/E Ratio39.91
EPS (TTM)$7.98
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$227.71
3 Months$216.24
1 Year Target$210.17

DHR Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Danaher Corporation (NYSE: DHR) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Danaher Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DHR on the NYSE shows an RSI of 69.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $210.17 for the NYSE listing.

Key metrics behind Danaher Corporation's NYSE-traded stock include a P/E ratio of 39.91 and a market capitalization of 159B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DHR on the NYSE.

Price Performance (NYSE: DHR)

1-Day Change
-0.48%
5-Day Change
2.60%
1-Month Change
4.70%
3-Month Change
17.35%
6-Month Change
24.63%
Year-to-Date (YTD) Change
-1.18%
1-Year Change
21.59%
3-Year Change
2.87%
5-Year Change
-16.76%
All-Time (Max) Change
37876.53%

Contact Information

202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

590,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions